Jutta Deininger

563 total citations
6 papers, 434 citations indexed

About

Jutta Deininger is a scholar working on Genetics, Molecular Biology and Rheumatology. According to data from OpenAlex, Jutta Deininger has authored 6 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Molecular Biology and 2 papers in Rheumatology. Recurrent topics in Jutta Deininger's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Kruppel-like factors research (2 papers). Jutta Deininger is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Kruppel-like factors research (2 papers). Jutta Deininger collaborates with scholars based in United States, Austria and Australia. Jutta Deininger's co-authors include Thomas G.P. Bumm, Brian Druker, Michael W. Deininger, Marc Loriaux, Lisa J. Wood, Amie S. Corbin, Christopher J. Burns, Emmanuelle Fantino, Jeffrey Tyner and Karl J. Aichberger and has published in prestigious journals such as Blood, Cancer Research and Breast Cancer Research.

In The Last Decade

Jutta Deininger

5 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jutta Deininger United States	4	314	242	220	125	114	6	434
Jeffrey Keats United States	8	118 0.4×	185 0.8×	165 0.8×	92 0.7×	156 1.4×	12	402
Mayuka Nakatake Japan	9	226 0.7×	246 1.0×	238 1.1×	71 0.6×	61 0.5×	14	431
Edward Kavalerchik United States	6	142 0.5×	188 0.8×	244 1.1×	58 0.5×	125 1.1×	17	358
Jason G. Harb United States	12	168 0.5×	385 1.6×	245 1.1×	45 0.4×	60 0.5×	30	570
Mary MacPartlin United States	6	193 0.6×	153 0.6×	229 1.0×	113 0.9×	84 0.7×	8	382
Wendy T Parker Australia	10	330 1.1×	118 0.5×	390 1.8×	170 1.4×	78 0.7×	22	537
Kim-Hien T. Dao United States	10	190 0.6×	309 1.3×	303 1.4×	80 0.6×	54 0.5×	13	566
Hardik Modi United States	10	222 0.7×	223 0.9×	351 1.6×	98 0.8×	82 0.7×	17	588
Hajime Akada United States	7	331 1.1×	244 1.0×	266 1.2×	101 0.8×	53 0.5×	12	437
Gautam Borthakur United States	12	215 0.7×	211 0.9×	415 1.9×	92 0.7×	82 0.7×	83	494

Countries citing papers authored by Jutta Deininger

Since Specialization

Citations

This map shows the geographic impact of Jutta Deininger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jutta Deininger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jutta Deininger more than expected).

Fields of papers citing papers by Jutta Deininger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jutta Deininger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jutta Deininger. The network helps show where Jutta Deininger may publish in the future.

Co-authorship network of co-authors of Jutta Deininger

This figure shows the co-authorship network connecting the top 25 collaborators of Jutta Deininger. A scholar is included among the top collaborators of Jutta Deininger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jutta Deininger. Jutta Deininger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Mooney, Colin, et al.. (2025). Evaluation and management of incomplete ovarian function suppression in premenopausal breast cancer patients receiving anti-hormone therapy. Breast Cancer Research. 27(1). 147–147.

2.

Tyner, Jeffrey, Thomas G.P. Bumm, Jutta Deininger, et al.. (2010). CYT387, a novel JAK2 inhibitor, induces hematologic responses and normalizes inflammatory cytokines in murine myeloproliferative neoplasms. Blood. 115(25). 5232–5240. 183 indexed citations

3.

Newell, Amy E. Hanlon, Sarah E. Fiedler, Jieyan Pan, et al.. (2008). Protein kinase A RII‐like (R2D2) proteins exhibit differential localization and AKAP interaction. Cell Motility and the Cytoskeleton. 65(7). 539–552. 43 indexed citations

4.

Agarwal, Anupriya, Thomas G.P. Bumm, Amie S. Corbin, et al.. (2008). Absence of SKP2 expression attenuates BCR-ABL–induced myeloproliferative disease. Blood. 112(5). 1960–1970. 54 indexed citations

5.

Bumm, Thomas G.P., Jeffrey Tyner, Jutta Deininger, et al.. (2008). Effects of CYT387, a Potent Novel JAK2 Inhibitor on JAK2-V617F Induced MPD. Blood. 112(11). 856–856. 3 indexed citations

6.

Bumm, Thomas G.P., Collin Elsea, Amie S. Corbin, et al.. (2006). Characterization of Murine JAK2V617F-Positive Myeloproliferative Disease. Cancer Research. 66(23). 11156–11165. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact